1. Tashkent Medical Academy Repository
  2. Tashkent Medical Academy Library
  3. Thesis, Articles
Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1913
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAzizova, Dilzoda-
dc.contributor.authorSobirova, Rikhsi-
dc.contributor.authorIslamova, Nodira-
dc.contributor.authorRahmanova, Z-
dc.contributor.authorAhmatova, K-
dc.contributor.authorAlimuhamedova, Mavjuda-
dc.date.accessioned2022-02-15T17:25:33Z-
dc.date.available2022-02-15T17:25:33Z-
dc.date.issued2022-
dc.identifier.issn2455-3301-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/1913-
dc.description.abstractThe study examined the effect of Biomaysa on the content of apoprotein in and total cholesterol, lipoprotein cholesterol and Lp FLA 2 in the dynamics of experimental hypercholesterolemia. Apoprotein B. of combined administration Biomaysa and ultroksa installed significant difference in the reduction of total cholesterol levels in ApoB 2.2 and 1.5, indicating good cholesterol reducing the effectiveness of the combination of these drugs by activating LDL receptor capture.en_US
dc.language.isoenen_US
dc.publisherWorld Journal of Pharma and medical researchen_US
dc.subjectexperimental hypercholesterolemia, blood, atherosclerosis, lipoproteins, cholesterol, apoprotein B, Lp FLA 2.en_US
dc.titleDEVELOP INTEGRATED DIAGNOSTIC BIOMARKERS OF ATHEROSCLEROSIS BASED ON EXPERIMENTAL STUDIESen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
article_1643624014.pdf605.71 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.